Eu Ivdd Eu Ivd Annex 2 List B On The Market 🇹🇼 Taiwan

GlucoSure Autocode

Apex Biotechnology Corp. · 🇹🇼 Taiwan
Devices (same UDI-DI)
1
Certificates
1
Countries
0
Notified Bodies
1

Basic Information

Primary DI
D-47136487601A05H
Basic UDI-DI Code
B-47136487601A05H
Reference
S70123, S70488
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd Annex 2 List B
Status
On The Market

Additional Description

The GlucoSure Autocode Blood Glucose Monitoring System is intended for the quantitative measurement of glucose in fresh capillary whole blood samples drawn from the fingertips, forearm, or palm. Testing is done outside the body (In Vitro diagnostic use). It is intended for both lay use by people with diabetes and in a clinical setting by healthcare professionals, as an aid to monitor levels in Diabetes Mellitus. It is not intended for the diagnosis or screening of diabetes or for neonatal use.

CND Nomenclature Codes

Code Description
W010106010801 BLOOD TEST STRIPS CONTROLS
W0101060101 GLUCOSE TEST STRIPS
W0201060102 BLOOD GLUCOSE METERS

Certificates

Type Number
IVDD Annex IV (excluding sections 4, 6) HL2100077-1

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Annex 2 List B) and regulation (EU IVDD).

View all